Varex director plans sale of 8,121 shares

Varex Imaging Corp (VREX) received a notice that director Jay K. Kunkel intends to sell common stock under Rule 144.

Available on EDGAR 09/14/2026 - 12:15 PM EDT Accepted by SEC EDGAR 09/14/2026 - 12:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Varex Imaging Corp (VREX) received a notice that director Jay K. Kunkel intends to sell common stock under Rule 144. The filing lists 8,121 shares of common stock associated with Fidelity Brokerage Services LLC and an indicated value of $150,076.08, to be sold on NASDAQ. The shares to be sold arise from restricted stock vesting events on February 11, 2024 (3,246 shares) and February 13, 2025 (4,875 shares), both granted as compensation by the issuer.

Key Figures

Common shares in Rule 144 notice: 8,121 shares Indicated value of shares: $150,076.08 Restricted stock vesting 2024: 3,246 shares +3 more

6 metrics

Common shares in Rule 144 notice 8,121 shares Listed in the securities information section for Varex Imaging Corp common stock

Indicated value of shares $150,076.08 Value associated with the 8,121 Varex Imaging Corp common shares

Restricted stock vesting 2024 3,246 shares Common shares from restricted stock vesting on February 11, 2024 as compensation

Restricted stock vesting 2025 4,875 shares Common shares from restricted stock vesting on February 13, 2025 as compensation

Form type Form 144 Notice of proposed sale of Varex Imaging Corp securities under Rule 144

Signature date September 14, 2026 Date shown in remarks and signature section for the Rule 144 notice

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 02/11/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Jay Kunkel"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for VREX disclose?

It discloses that director Jay K. Kunkel intends to sell Varex Imaging Corp (VREX) common stock under Rule 144, with the sale to be executed through Fidelity Brokerage Services LLC and listed for trading on NASDAQ.

How many VREX shares are covered by Jay Kunkel’s Form 144?

The filing lists 8,121 shares of Varex Imaging Corp common stock in the securities information section, with an indicated value of $150,076.08, to be sold through Fidelity Brokerage Services LLC on NASDAQ.

What is the source of the VREX shares Jay Kunkel plans to sell?

The shares come from restricted stock vesting awarded as compensation by Varex Imaging Corp: 3,246 common shares vested on February 11, 2024 and 4,875 common shares vested on February 13, 2025.

What role does Jay K. Kunkel have at Varex Imaging Corp (VREX)?

Jay K. Kunkel is identified in the filing as a Director of Varex Imaging Corp, and the Form 144 relates to planned sales of common stock for his account.

Who is executing the planned VREX share sale under this Form 144?

The planned sale is associated with Fidelity Brokerage Services LLC, which appears in the securities information section for the Varex Imaging Corp common stock to be sold on NASDAQ.

When is the date related to the Form 144 for VREX?

The document includes the date September 14, 2026 in both the securities information section and the remarks and signature section, tying that date to the planned Rule 144 sale disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001592005
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Varex Imaging Corp
SEC File Number	001-37860
Address of Issuer	1678 S. PIONEER ROAD SALT LAKE CITY UTAH 84104
Phone	801-972-5000
Name of Person for Whose Account the Securities are To Be Sold	Kunkel Jay K.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8121	150076.08	42100000	09/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2024	Restricted Stock Vesting	Issuer			3246	02/11/2024	Compensation
Common	02/13/2025	Restricted Stock Vesting	Issuer			4875	02/13/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jay Kunkel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)